(Q58279991)

English

Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study

scientific article published on 23 March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22439807%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22439807%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

based on heuristic

inferred from title

metabolic syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22439807%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Davide Francomano

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22439807%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Emanuela A. Greco

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22439807%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22439807%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Silvia Migliaccio

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22439807%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Roberto Bruzziches

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22439807%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Rachele Fornari

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22439807%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Luigi Di Luigi

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22439807%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

23 March 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22439807%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22439807%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22439807%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22439807%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

96-102

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22439807%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Osteoporosis prevention, diagnosis, and therapy

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Screening for osteoporosis in men: a systematic review for an American College of Physicians guideline

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Structural decay of bone microarchitecture in men with prostate cancer treated with androgen deprivation therapy

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

IGF-I and testosterone levels as predictors of bone mineral density in healthy, community-dwelling men.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Testosterone, cardiovascular disease and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Testosterone and metabolic syndrome: a meta-analysis study

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Androgen regulation of prostate cancer: where are we now?

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Bone mineral density in elderly men and women: results from the Framingham osteoporosis study

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Bone loss, physical activity, and weight change in elderly women: the Dubbo Osteoporosis Epidemiology Study

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Obesity and fractures in postmenopausal women.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

The metabolic syndrome--a new worldwide definition

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

The Aging Males' Symptoms scale (AMS) as outcome measure for treatment of androgen deficiency

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Monitoring skeletal changes by radiological techniques.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Osteoblast and osteocyte apoptosis associated with androgen action in bone: requirement of increased Bax/Bcl-2 ratio

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

The immune system and bone

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Bone mineral density in adults with the metabolic syndrome: analysis in a population-based U.S. sample

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Features of the metabolic syndrome and the risk of non-vertebral fractures: the Tromsø study.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

The relationship between low bone mass and metabolic syndrome in Korean women.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Negative association between metabolic syndrome and bone mineral density in Koreans, especially in men.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Metabolic syndrome and bone metabolism: the Camargo Cohort study.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Free testosterone is a positive, whereas free estradiol is a negative, predictor of cortical bone size in young Swedish men: the GOOD study

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Effect of testosterone and estradiol in a man with aromatase deficiency

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Estrogen receptor-alpha dependency of estrogen's stimulatory action on cancellous bone formation in male mice

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

A four-year efficacy and safety study of the long-acting parenteral testosterone undecanoate

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Onset of effects of testosterone treatment and time span until maximum effects are achieved

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.631230

21 January 2018

Identifiers

10.3109/13685538.2011.631230

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22439807%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22439807%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58279991&oldid=2095603579"